A UK biotech start-up has secured $14mn in early-stage funding led by MSD Global Health Innovation Fund to develop vaccines that are “future-proofed” by artificial intelligence.
Baseimmune uses AI to help it predict future pathogen mutations with the goal of creating jabs for coronavirus, malaria and African swine fever that will be more effective for longer.
您已阅读15%（501字），剩余85%（2784字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。